959581-02-3 Usage
Uses
Used in Pharmaceutical Industry:
BOC-(TRANS)-4-(2-FLUORO-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID is used as a synthetic intermediate for the development of new pharmaceuticals. Its unique structure allows for the creation of novel drug candidates with potential therapeutic applications, such as treating various diseases and disorders.
Used in Organic Synthesis:
In the field of organic synthesis, BOC-(TRANS)-4-(2-FLUORO-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID serves as a versatile building block for the synthesis of complex organic molecules. Its reactivity and structural features enable chemists to create a wide range of compounds with diverse properties and potential applications.
Used in Chemical Research:
BOC-(TRANS)-4-(2-FLUORO-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID is also utilized in chemical research to explore new reaction pathways and mechanisms. Its unique structure provides opportunities for studying the effects of fluorination on molecular properties and reactivity, contributing to the advancement of synthetic chemistry and related fields.
Check Digit Verification of cas no
The CAS Registry Mumber 959581-02-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,5,8 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 959581-02:
(8*9)+(7*5)+(6*9)+(5*5)+(4*8)+(3*1)+(2*0)+(1*2)=223
223 % 10 = 3
So 959581-02-3 is a valid CAS Registry Number.
InChI:InChI=1/C16H20FNO4/c1-16(2,3)22-15(21)18-8-11(12(9-18)14(19)20)10-6-4-5-7-13(10)17/h4-7,11-12H,8-9H2,1-3H3,(H,19,20)/t11-,12+/m1/s1
959581-02-3Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
-
Paragraph 00392; 00408, (2021/09/04)
The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.
Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: Discovery of the dihydropyridazinone motif
Ujjainwalla, Feroze,Warner, Daniel,Snedden, Christine,Grisson, Ricky D.,Walsh, Thomas F.,Wyvratt, Matthew J.,Kalyani, Rubana N.,MacNeil, Tanya,Tang, Rui,Weinberg, David H.,Van Der Ploeg, Lex,Goulet, Mark T.
, p. 4023 - 4028 (2007/10/03)
Optimization of the biological activity of a new class of non-peptidyl, pyridazinone derived human melanocortin subtype-4 receptor agonists is disclosed.
